Align Technology reported its third-quarter financial results, revealing better-than-expected revenue and adjusted earnings per share. The company generated $1.01 billion in revenue, surpassing analyst estimates of $1.00 billion, marking a year-on-year increase of 1.9%. Adjusted earnings per share stood at $2.80, beating expectations of $2.76.
CEO Joe Hogan noted strong demand for Clear Aligners and increased shipments among orthodontists and general practitioners. He also highlighted record engagement from doctors, stating, “record doctor submitters” helped boost sales volumes despite a challenging environment for discretionary dental spending. The operating margin improved to 16.7%, up from 9.7% in the same quarter last year.
Analysts posed several key questions during the earnings call, reflecting concerns and strategic direction.
Top Analyst Questions from Align Technology’s Q3 Earnings Call
-
Michael Cherny of Leerink Partners inquired about the disparity between strong Q3 case starts and more conservative Q4 guidance. Hogan attributed this caution to ongoing consumer reluctance and global macroeconomic pressures.
-
Jonathan Block from Stifel asked if the company’s new sports mouthguard signaled a broader move into adjacent product categories. Hogan clarified that the mouthguard leverages existing distribution channels and is distinct from previous initiatives, like those involving sleep apnea.
-
Brandon Vazquez of William Blair questioned the effects of changing market conditions in North America and China. Hogan noted improved orthodontic growth in the U.S. but acknowledged ongoing challenges for general practitioners.
-
Elizabeth Anderson from Evercore ISI sought information on scanner demand and the shift toward leasing. CFO John Morici explained that flexible acquisition options are expanding the customer base, while scanner pricing has stabilized after recent declines.
-
Jeffrey Johnson from Baird inquired about the impact of China’s value-based procurement policy. Morici indicated that, although this policy may exert pressure on prices, it could also lead to increased adoption of Clear Aligners in the largely untapped Chinese market.
Align Technology is currently trading at $149.69, down from $153.62 prior to the earnings announcement. The performance of the stock will be closely watched as the company navigates future market conditions and strategic developments.
